Study of Ropivacaine, a local anaesthetic drug, to assess pain after tonsillectomy.

Efficacy of Pre-incisional infiltration of Ropivacaine for Post Tonsillectomy Pain Relief.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035851

Enrollment

Registered

2021-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J350- Chronic tonsillitis and adenoiditis

Interventions

Intervention1: 0.2ml/kg of 0.75% of Ropivacaine Hydrochloride.: All Patients will be divided in 2 groups. Group R will be administered 0.2ml/kg of 0.75% Ropivacaine hydrochloride infiltration into eac

Eligibility

Inclusion criteria

Inclusion criteria: with or without adenoids. Patients with chronic tonsillitis with last episode of tonsillitis occurring 3 weeks prior to procedure. ASA grade 1 or 2

Exclusion criteria

Exclusion criteria: Patients with acute attack of tonsillitis, peritonsillar abscess, bleeding disorder and anaemia. Patients undergoing other ENT procedures like myringotomy Patients hypersensitive to Ropivacaine Patients below the age of 5 years and above the age of 50 years ASA grade 3 or more Patients not willing for surgery

Design outcomes

Primary

Measure	Time frame
To study the effect of pre-incisional infiltration of Ropivacaine for post tonsillectomy pain relief.Timepoint: 0 hours, 4 hours and 8 hours after surgery.	—

Secondary

Measure	Time frame
To study the effect of pre-incisional infiltration of Ropivacaine for post tonsillectomy pain relief.Timepoint: 24 hours and 48 hours after surgery	—

Countries

India

Contacts

Public ContactDr Aastha Bhatnagar

Dr. D.Y. Patil Vidyapeeth, Pune

jaytees66@yahoo.co.in9422015828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026